2017-08-17 13:16:41 UTC

Risk Factors of Prednisolone May Outweigh Benefit in Treatment of Severe Alcoholic Hepatitis (SAH)

Aug. 17, 2017

Gastroenterology researchers discuss their findings in video abstract.

Prednisolone is advocated for treatment of severe alcoholic hepatitis (SAH), but can increase susceptibility to infection. In the video below, Mark Thusz, MD,  Stephen Atkinson  and Nikhil Vergis, BMBCH, MRCP, discuss their findings, “In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNA,” published in Gastroenterology


More on Hepatitis (other)

Tumor Necrosis Factor-producing T-regulatory Cells Are Associated With Severe Liver Injury in Patients With Acute Hepatitis A

March 1, 2018

Treg cells from AHA patients produce TNF and have reduced suppressive activity. TNF-producing Treg cells are associated with severe liver injury in AHA patients.

FDA Announces GREAT 5 Public Workshop

Feb. 16, 2018

The three-day public workshop will focus on alcoholic hepatitis and liver disease, and pediatric IBS and functional constipation.

2018 AGA Postgraduate Course Resources

Jan. 17, 2018

Pre-order resources from the course when you register.